PRISM BioLab Co.,LTD 206AShort Interest
No institution currently reports a short position of 0.5% or more in PRISM BioLab Co.,LTD (206A). The last disclosure was on 2026-11-09 (Nomura International plc, 0.47%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
308 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 7 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2024-07-10 |
|---|---|
| Latest disclosure | 2026-11-09 (Nomura International plc, 0.47%) |
| Reporting institutions | 7 firms (308 reports) |
| Peak estimated short interest | 4.70% (2026-04-10, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Morgan Stanley MUFG Securities Co., Ltd.
- Nomura International plc
- UBS AG
- GOLDMAN SACHS INTERNATIONAL
- JPM Securities Japan Co Ltd.
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-09-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 181,800 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2024-11-19 | Barclays Capital Securities Ltd | Position 178,420 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2025-12-03 | JANE STREET GLOBAL TRADING, LLC | Position 182,209 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2026-11-09 | Nomura International plc | Position 175,200 shares | Ratio 0.47% | ▼0.06% | Below 0.5% |
| 2025-12-24 | JPM Securities Japan Co Ltd. | Position 165,000 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2026-07-16 | GOLDMAN SACHS INTERNATIONAL | Position 147,300 shares | Ratio 0.39% | ▼0.11% | Below 0.5% |
| 2025-12-02 | UBS AG | Position 92,700 shares | Ratio 0.25% | ▼0.37% | Below 0.5% |
Disclosure History 308 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-09 | Nomura International plc | Position 175,200 shares | Ratio 0.47% | ▼0.06% | Below 0.5% |
| 2026-11-06 | Nomura International plc | Position 198,900 shares | Ratio 0.53% | ▼0.13% | — |
| 2026-11-02 | Nomura International plc | Position 245,400 shares | Ratio 0.66% | ▲0.14% | — |
| 2026-10-29 | Nomura International plc | Position 196,100 shares | Ratio 0.52% | ▲0.03% | — |
| 2026-10-28 | Nomura International plc | Position 182,100 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2026-10-08 | Nomura International plc | Position 196,000 shares | Ratio 0.52% | ▲0.07% | — |
| 2026-10-02 | Nomura International plc | Position 169,700 shares | Ratio 0.45% | ▼0.10% | Below 0.5% |
| 2026-10-01 | Nomura International plc | Position 204,600 shares | Ratio 0.55% | ▲0.18% | — |
| 2026-09-18 | Nomura International plc | Position 182,500 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-09-16 | Nomura International plc | Position 191,600 shares | Ratio 0.51% | ▲0.03% | — |
| 2026-09-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 181,800 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2026-09-08 | Nomura International plc | Position 253,300 shares | Ratio 0.68% | ▼0.10% | — |
| 2026-09-03 | Nomura International plc | Position 288,700 shares | Ratio 0.78% | ▼0.02% | — |
| 2026-09-02 | Nomura International plc | Position 296,800 shares | Ratio 0.80% | ▲0.03% | — |
| 2026-09-01 | Morgan Stanley MUFG Securities Co., Ltd. | Position 220,600 shares | Ratio 0.59% | ▼0.09% | — |
| 2026-08-27 | Nomura International plc | Position 287,700 shares | Ratio 0.77% | ▼0.11% | — |
| 2026-08-27 | Morgan Stanley MUFG Securities Co., Ltd. | Position 254,700 shares | Ratio 0.68% | ▼0.11% | — |
| 2026-08-24 | Nomura International plc | Position 328,600 shares | Ratio 0.88% | ▼0.03% | — |
| 2026-08-21 | Nomura International plc | Position 337,600 shares | Ratio 0.91% | ▲0.03% | — |
| 2026-08-21 | Morgan Stanley MUFG Securities Co., Ltd. | Position 293,200 shares | Ratio 0.79% | ▼0.10% | — |
| 2026-08-20 | Nomura International plc | Position 326,000 shares | Ratio 0.88% | ▼0.02% | — |
| 2026-08-10 | Nomura International plc | Position 334,300 shares | Ratio 0.90% | ▲0.05% | — |
| 2026-08-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 332,400 shares | Ratio 0.89% | ▼0.01% | — |
| 2026-08-03 | Morgan Stanley MUFG Securities Co., Ltd. | Position 334,900 shares | Ratio 0.90% | ▲0.01% | — |
| 2026-07-31 | Nomura International plc | Position 315,900 shares | Ratio 0.85% | ▼0.06% | — |
| 2026-07-31 | Morgan Stanley MUFG Securities Co., Ltd. | Position 331,200 shares | Ratio 0.89% | ▼0.03% | — |
| 2026-07-30 | Morgan Stanley MUFG Securities Co., Ltd. | Position 340,300 shares | Ratio 0.92% | ▼0.08% | — |
| 2026-07-28 | Nomura International plc | Position 337,500 shares | Ratio 0.91% | ▲0.08% | — |
| 2026-07-28 | Morgan Stanley MUFG Securities Co., Ltd. | Position 369,900 shares | Ratio 1.00% | ▲0.01% | — |
| 2026-07-24 | Morgan Stanley MUFG Securities Co., Ltd. | Position 367,400 shares | Ratio 0.99% | ▼0.07% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Veritas In Silico Inc.130A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chordia Therapeutics Inc.190A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAUNS Laboratories,Inc.197A | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Heartseed Inc.219A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Astellas Pharma Inc.4503 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| Innovacell Inc.504A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| J-Pharma Co.,Ltd.520A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |